Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Growth of Hemangioma Tumors in Newborn: A Prospective Randomized Clinical Study

NCT01873131 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01873131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01873131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Growth of Hemangioma Tumors in Newborn: A Prospective Randomized Clinical Study
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 28, 2011
Completion date
December 31, 2028
Enrollment
126 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemangioma